The GCIG Spring meeting was held in Chicago on June 1 - 3, 2022. CEEGOG was represented there by its Chairman, Prof. David Cibula.

During the Cervix committee meeting and the Cervix Cancer Research Network meeting, David Cibula provided an update on the ongoing CEEGOG trial called CERVANTES (A prospective randomized trial on the role of radical surgery and adjuvant therapy in the management of intermediate / high-risk cervical cancer patients; CEEGOG CX-05/ENGOT-cx16).

It was agreed to schedule an endometrial cancer consensus conference focused on clinical trial questions in the near future (next year).

The results from the survey focusing on patient involvement in research within the Gynecological Cancer InterGroup have shown the importance of the call of action for a systematic approach. Therefore, this topic will be included in the agenda of the next Harmonization operations committee meetings.